Robert Goodlett, MD
Obstetrics · Spartanburg, SCNPI 1780630475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations.
Across 124 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$328
- Channel Medsystems, Inc.$286
- Astellas Pharma US Inc$264
- Daiichi Sankyo Inc.$142
- Amgen$125
- Bayer$118
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,24598%
- Education$382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $328 |
| Channel Medsystems, Inc. | 2 | $286 |
| Astellas Pharma US Inc | 16 | $264 |
| Daiichi Sankyo Inc. | 7 | $142 |
| Amgen | 8 | $125 |
| Bayer | 8 | $118 |
| Pfizer | 9 | $117 |
| Coopersurgical, Inc. | 4 | $116 |
| Therapeuticsmd, Inc. | 7 | $88 |
| Exeltis, USA Inc. | 5 | $87 |
| Mayne Pharma Commercial LLC | 7 | $81 |
| Sumitomo Pharma America, Inc. | 3 | $68 |
| Organon | 4 | $67 |
| Optumhealth Care Solutions, LLC | 3 | $60 |
| Sage Therapeutics, LLC | 3 | $53 |
| Lupin Inc. | 3 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| AMAG Pharmaceuticals, Inc. | 3 | $38 |
| Avion Pharmaceuticals | 2 | $25 |
| Myovant Sciences Inc. | 1 | $22 |
| Scynexis, Inc. | 1 | $19 |
| Covidien LP | 1 | $18 |
| Roche Diagnostics Corporation | 1 | $18 |
| Avanos Medical | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Aspira Women's Health Inc | 1 | $15 |
| Meditrina | 1 | $14 |
How this compares
Too few obstetrics providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 27 | $12,140 |
| PremarinEstrogens, Conjugated | 16 | $9,963 |
| Estradiol | 245 | $8,627 |
| YuvafemEstradiol | 27 | $5,263 |
| PremproEstrogen,con/M-Progest Acet | 13 | $5,231 |
| Mirabegron ErMirabegron | 11 | $4,010 |
| Estradiol (Twice Weekly)Estradiol | 13 | $1,633 |
| ValacyclovirValacyclovir Hcl | 23 | $959 |
| Fluconazole | 64 | $541 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 14 | $528 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 28 | $499 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 39 | $471 |
| Metronidazole | 12 | $289 |
| Medroxyprogesterone Acetate | 18 | $269 |
| Lorazepam | 45 | $176 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin, Prempro | $117 | $15,19429 claims |
| Astellas Pharma US IncMyrbetriq | $264 | $12,14027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few obstetrics providers in South Carolinaon file to place this against a meaningful peer group, so we don't.
Other obstetrics in Spartanburg
- Brandi HardinSpartanburg$281K
- Roberto PereyoSpartanburg$2K
- Ashley BensonSpartanburg$2K
- Robert ArnettSpartanburg$684
- William JamesSpartanburg$90
- James JohnsonSpartanburg$64
- John ScottSpartanburg$28
- Edward KowalFlorence$10K
- William ReevesSummerville$5K
- Katherine ColeyBluffton$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.